거래 정지 중인 종목 2026-06-04 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.
ABP
Abpro Holdings Inc
$0.52
+0.00 +0.00%
앱프로 홀딩스(ABP) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
시가총액
$1M
스몰캡
P/E
-
배당수익률
없음
52주 위치
0%
저점 +1% · 고점 -98%
애널리스트
보유
F
Fundamental health
vs. 전체 시장· based on 1 axes
수익성 산출 불가 (적자)
성장 데이터 부족
밸류에이션 데이터 부족
재무 안정 Top 92%
| Index | - | P/E | - | EPS (ttm) | -12.45 | Insider Own | 36.26% | Shs Outstand | 2.7M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.7M | Perf Month | -72.53% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 1.71% | Short Float | 2.6% | Perf Quarter | -91.79% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | -11.1% | Short Ratio | 0.03 | Perf Half Y | -93.2% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -248.15% | Short Interest | 0.04M | Perf YTD | -87.66% |
| Book/sh | -6.04 | P/C | 4.18 | EPS past 3/5Y | -2359.24% - | ROE | - | 52W High | -98.26% ($29.97) | Perf Year | -98.15% |
| Cash/sh | 0.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 0.96% ($0.52) | Perf 3Y | -99.83% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -95.93% | Gross Margin | - | Volatility(W/M) | 35.22% 26.35% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.07 | EPS Q/Q | 48.6% | Profit Margin | - | RSI (14) | 22.04 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.07 | Sales Q/Q | - | SMA20 | -65.53% ($1.51) | Beta | 0.11 | Target Price | $60 |
| Payout | - | Debt/Eq | - | Earnings | 2025/09/03 | SMA50 | -84.13% ($3.28) | Rel Volume | 0 | Prev Close | $0.52 |
| Employees | 6 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -90.96% ($5.75) | Avg Volume(3M) | 1.67M | Price | $0.52 |
| IPO | 2022/3/9 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.
Abpro Holdings Inc (ABP) Investment Analysis
What kind of company is Abpro Holdings Inc?
앱프로 홀딩스(ABP)
Healthcare · Biotechnology
Small-Cap — Low Volume, High Volatility
🧬 Aprogen Holdings (ABP) is a next-generation immuno-oncology drug discovery biotech company that develops bispecific antibodies for solid tumor-targeted therapies such as breast cancer and gastric cancer using its proprietary DiversiMab platform technology.
Learn more about Abpro Holdings Inc →Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5836
Employees6people
IPO2022/03/09
Current Price$0.52 ≈ 712원
Key Events
예정된 이벤트가 없습니다
ABP의 다음 실적 발표일이나 배당 일정이 아직 수집되지 않았습니다.
- 실적 발표는 보통 분기마다 있습니다
- 배당주는 연 1~4회 배당락일이 있습니다
Is it profitable?
Both profitability & finances need caution
Review management risk carefully before investing
Profitability — How efficiently it makes money
ROA
Annual earnings relative to total company assets
-248.2%
✓ 적자
Financial health — Debt & liquidity burden
Current Ratio
Liquid assets available to cover liabilities due within a year
0.07
✓ 위험
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.07
✓ 위험
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).
What's the outlook?
Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$60.00
현재가 대비 +11438.5%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.
Did earnings meet expectations?
Insufficient historical earnings data
No analyzable past earnings releases have been collected yet.
Is it growing?
Average Growth
Mid-range within the industry
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
-2359.2%
매우 부진
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →
Has the stock risen over the long term?
Underperformed the market by 114%p over the past year
ABP -98.2% · S&P 500 +16.0%
Excess return vs. market (price-based, ex-dividends)
1-year basis
vs S&P 500
-114.2%p
Significantly behind the market
vs Health Care (XLV)
-117.9%p
Significantly behind the sector average
Current position within 52-week range
Low (-1.0%p) High (-98.3%p)
Current price is 1.0% above the 52-week low and 98.3% below the 52-week high
Recent risk (last 31 trading days)
Max drawdown
-77.9%
Annualized volatility
238.7%
Is it attractive at this price?
Valuation data is insufficient
Key metrics such as PER and PBR are unavailable, so valuation is omitted.
Who owns it?
Ownership flow shows some pressure
Institutional net selling -11.1% · Short interest light 2.6% · Short interest up +2.0pp over last 31d
📈 Recent trading flow (6 months)
🧑💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
-11.1%
Institutions large net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 1.7%
Retail-led
🧑💼 Insiders 36.3%
Founder/management large holders (strong skin-in-the-game)
👤 Retail investors (estimated) 62.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
2.6%
Low — limited short-side pressure
Past 31 days 📈 +2.0%p increase
Short interest days to cover
0.0 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 2.7M주
Float (tradable shares) 1.7M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 31 days.
How much does it pay in dividends?
This company does not pay a dividend
It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.
Compare Industry Peers
💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
| Stock | Market Cap | PER | PBR | ROE | Dividend Yield | Change |
|---|---|---|---|---|---|---|
| ABP This Stock | $1.4M | - | - | - | - | +0.0% |
LLY | $1.13T | 43.1 ▼ | 36.2 ▼ | 107.64% ▲ | 0.58% ▼ | +0.1% |
JNJ | $640.9B | 30.8 ▼ | 7.5 ▼ | 25.74% ▲ | 2.02% ▲ | +1.0% |
ABBV | $453.9B | 126.7 ▼ | - | 15221.82% ▲ | 2.67% ▲ | -0.9% |
UNH | $379.3B | 26.9 ▼ | 3.9 ▼ | 12.49% ▲ | 2.16% ▲ | -0.7% |
MRK | $323.0B | 36.8 ▼ | 7.0 ▼ | 18.97% ▲ | 2.5% ▲ | -0.2% |
| Sector Avg | - | 26.1 | 2.7 | -48.83% | 1.23% | - |
FAQ
What kind of company is 앱프로 홀딩스(ABP)?
앱프로 홀딩스(ABP) belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of ABP?
The market cap of ABP is approximately $1M, ranking 5,836 within its sector.
What is the 52-week high and low for ABP?
ABP has recorded a 52-week high of $29.97 and a low of $0.52.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.